Inspire Medical Systems, Inc. (NYSE: INSP) is a Healthcare company (Medical - Devices) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
Inspire Medical Systems, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $59.41, Inspire Medical Systems, Inc. trades at 16.8x trailing earnings, 1.9x sales and 2.1x book value, with an EV/EBITDA of 33.8. Over the last twelve months it generated about $893M of revenue and $102M of net income. It runs a gross margin of 86.2%, an operating margin of 1.8% and a net margin of 11.4%. It shows return on equity of 12.5%, return on invested capital of 1.8% and a free cash flow yield of 5.7%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 6.45. Over the past 52 weeks the share price ranged from $38.91 to $147.03, with a beta of 0.65.
Inspire Medical Systems, Inc. does not currently pay a dividend.
29 Wall Street analyst ratings cover the stock: 12 Buy, 16 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Inspire Medical Systems, Inc. (INSP) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 24.3% / 30% · Interest income / Revenue 1.89% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 17.0% / 33% · Receivables / Mkt Cap (36m) 5.42% / 49% · Interest income / Revenue 1.89% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 17.0% / 33.33% · Receivables / Mkt Cap (24m) 5.42% / 33.33% · Interest income / Revenue 1.89% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.00% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 33.6% / 33.33% · Receivables / Avg Assets (4Q) 11.7% / 33.33% · Interest income / Revenue 1.89% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 34.4% / 33.33% · (Cash+Recv) / Total Assets 45.4% / 33.33% · Interest income / Revenue 1.89% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Inspire Medical Systems, Inc. (INSP) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Inspire Medical Systems, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 1.89% of each dividend: Inspire Medical Systems, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.